Biofrontera shares are trading higher after the company announced a Notice of Allowance on its U.S. patent titled ‘Illumination for Photodynamic Therapy’.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.